Form 4 for CTKB Cytek Biosciences, Inc.
Accepted 2026-06-16 16:59:02 ET · period of report 2026-06-12 · accession 0001874041-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-16 16:59 | 2026-06-12 | CTKB | Yan Ming | CTO, Dir | G - Gift | $0.00 | -135.9K | 4.80M | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-12 | G | D | 135,892 | $0.00 | 4,796,688 | D | — | — |